Home > Media Centre > Press Releases
Press releases
AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI
€23m (US$25.5m) equity provided mainly by US-based Cowen…
AM-Pharma Expands its Senior Team in Preparation for a Pivotal Phase III Trial of recAP in Acute Kidney Injury
Juliane Bernholz has joined as Chief Operating Officer
…
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury
Financing co-led by new investors LSP and Andera Partners, with…
Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury
You can read the whole publication by clicking on this button
View…
JAMA publishes Phase II recAP data for sepsis-associated Acute Kidney Injury
JAMA paper to be presented at ESICM conference in Paris
New…